SEC Form 4 · accession 0001179110-18-005604

MOMENTA PHARMACEUTICALS INC · MNTA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President & CEO · Director

Period of report

Apr 10, 2018

Accepted (ET)

Apr 12, 2018 · 4:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001235010

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Apr 10, 2018	M	33,334	$10.43	A	230,913	D
Common Stock^F3	Apr 10, 2018	S	33,334	$19.00	D	197,579	D
Common Stock^F3,F4	Apr 10, 2018	S	10,000	$19.00	D	359,645	I	Craig Wheeler Revocable Trust
Common Stock	holding	—	—		—	45,980	I	Craig A Wheeler 2016 Annuity Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)	$10.43	Apr 10, 2018	M	33,334	D	Nov 25, 2012	Feb 25, 2019	Common Stock	33,334	55,269	D

F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2016.
F2Reflects a decrease of 40,321 shares of MNTA common stock transferred to the Craig Wheeler Revocable Trust on February 27, 2018.
F3This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4Reflects the transfer of 40,321 shares of MNTA common stock on February 27, 2018 to the Craig Wheeler Revocable Trust that were previously held directly by Mr. Wheeler.